Congressmen share our MOU concerns, support us with OMB

Published June 10, 2020

Seven members of Congress have written to OMB, sharing the same concerns we have about FDA’s MOU on interstate shipments of compounded drugs: As written, it will place a tremendous and undue burden on state boards of pharmacy. Read the letter at files/Advocacy/2020-06-08_Letter-to-OMB-on-MOU.pdf